Technology That Redefines What Brain Stimulation Can Achieve
Our Technology in El Paso delivering advanced transcranial magnetic stimulation for patients who haven't responded to medication alone
NeuroWave TMS, LLC uses Apollo TMS, a system engineered in Germany with FDA-cleared components designed to address treatment-resistant depression and anxiety disorders. The platform features a short biphasic pulse that reduces discomfort during treatment and a high-performance coil geometry that directs magnetic energy more precisely than older TMS systems. The device interface was designed with patient comfort in mind, minimizing the clinical feel of treatment sessions and replacing it with a setup that feels more like a wellness appointment than a medical procedure.
The system's biphasic pulse width ranks among the shortest available in commercial TMS platforms, which translates to less sensation during stimulation and fewer reports of scalp discomfort across sessions. Coil design matters because it determines how focused the magnetic field remains as it reaches cortical tissue, and Apollo's geometry maintains field strength while narrowing the stimulation zone compared to figure-eight coils used in earlier generations of TMS.
Request a consultation to review whether this platform matches your treatment history and symptom profile.
The biphasic pulse used in Apollo TMS alternates current direction within the coil faster than traditional monophasic systems, which reduces the total energy delivered to scalp nerves while maintaining the necessary intensity to reach cortical neurons. This means patients feel less tapping or knocking sensation during each pulse train, which improves tolerance over the course of a four-to-six-week protocol requiring daily sessions. The coil's construction includes thermal management features that prevent overheating during back-to-back appointments, allowing consistent performance across a full day of scheduled treatments.
After completing a course of treatment, patients typically notice improved mood regulation, reduced rumination, and better response to situations that previously triggered withdrawal or irritability. Sleep patterns often normalize within the first few weeks as depressive symptoms diminish. Concentration improves as the brain regions responsible for executive function regain baseline activity levels, which makes returning to work or managing daily responsibilities feel less effortful.
The system does not require anesthesia, does not involve implanted hardware, and does not produce systemic side effects like weight changes or sexual dysfunction commonly associated with pharmacologic treatments. Treatment sessions last approximately twenty minutes, and patients drive themselves to and from appointments without restriction.
Questions About the Platform and Treatment Process
The details below address how the technology works and what differentiates it from other approaches to depression treatment.
What does the short biphasic pulse actually change during treatment?
The shorter pulse duration reduces the activation of pain receptors in the scalp while still depolarizing neurons in the targeted cortical region, which is why patients report less discomfort compared to older monophasic systems that required longer pulse widths to achieve therapeutic effect.
How does coil design affect treatment precision?
A high-performance coil focuses the magnetic field into a smaller area of the cortex, reducing unintended stimulation of adjacent brain regions and allowing the clinician to target the dorsolateral prefrontal cortex with millimeter-level accuracy based on anatomical landmarks.
Why does the German engineering designation matter?
Manufacturing standards in Germany require tighter tolerances for electromagnetic components, which means coil output remains consistent across thousands of pulses and the system maintains calibration longer between service intervals compared to devices built to looser specifications.
What happens if someone experiences discomfort during a session?
The intensity can be adjusted in real time without stopping the session, and most patients acclimate to the sensation within the first week as the nervous system adapts to the repetitive stimulation pattern.
How long do results typically last after finishing the initial series?
Many patients maintain improvement for six months or longer, and some require periodic maintenance sessions if symptoms begin to return, though the frequency of maintenance varies based on individual response and whether other therapies like counseling or medication continue alongside TMS.
NeuroWave TMS, LLC provides access to this platform for patients in El Paso who have tried multiple antidepressants without sufficient relief. Schedule an evaluation to determine eligibility and review insurance coverage options.
FDA Approved:
